Vol.

No.

November 15, 2019Nov 15, 2019

DOWNLOAD THE PDF

U.S. Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy

Cover Story

Conversation with The Cancer Letter Free

U.S. Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy

By Alexandria Carolan

William Kaelin and Gregg Semenza have a message for young scientists: do science for its own sake—and enjoy it.

Conversation with The Cancer Letter

Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA

By Paul Goldberg

White papers by Friends address external controls, progression on immunotherapy, companion diagnostics

By Matthew Bin Han Ong

Clinical Free Trials & Tribulations

Noorchashm: “Biopsy your tumors”—with failed fibroid guidelines, gynecologists might as well be reading tea leaves

By Hooman Noorchashm

In Brief

Ashwani Rajput named director of The Johns Hopkins Kimmel Cancer Center

VUMC's Rathmell to Receive 2019 Eugene P. Schonfeld Award

St. Baldrick's Foundation awards nearly $1.5M in grants to expand children's clinical trials

Moffitt collaborates with VA hospitals to expand clinical cancer research

Drugs & Targets

FDA grants Breakthrough Device Designation for Exact Sciences blood-based test for detection of HCC

FDA accepts BMS application for Opdivo + Yervoy for liver cancer

Janssen seeks FDA approval for Imbruvica + rituximab for previously untreated patients with CLL

Canada approves Imbruvica combination for CLL indication

UroGen receives rights to Zalifrelimab for intravesical treatment of urinary tract cancers

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 46 - December 13, 2024